Impact of angiotensin receptor blockers on Alzheimer disease neuropathology in a large brain autopsy series

Archives of Neurology

Volumn 69, Issue 12, 2012, Pages 1632-1638

  Hajjar, Ihab ^a   Brown, Lauren ^a   Mack, Wendy J ^a   Chui, Helena ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; ALZHEIMER DISEASE; AMYLOID NEUROPATHY; ARTICLE; AUTOPSY; BRAIN ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; DISEASE MARKER; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; PATIENT COMPLIANCE; PATIENT REFERRAL; PRIORITY JOURNAL; SENILE PLAQUE;

EID: 84871195370     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2012.1010     Document Type: Article

References (19)

1. Li NC, Lee A, Whitmer RA, et al. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ. 2010;340:b5465.
2. Guan JW, Huang CQ, Li YH, et al. No association between hypertension and risk for Alzheimer's disease: a meta-analysis of longitudinal studies. J Alzheimers Dis. 2011;27(4):799-807.
3. Israeli-Korn SD, Masarwa M, Schechtman E, et al. Hypertension increases the probability of Alzheimer's disease and of mild cognitive impairment in an Arab community in northern Israel. Neuroepidemiology. 2010;34(2):99-105.
4. Yang YH, Roe CM, Morris JC. Relationship between late-life hypertension, blood pressure, and Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2011;26(6):457-462.
5. Selkoe DJ. Toward a comprehensive theory for Alzheimer's disease: hypothesis, Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann N Y Acad Sci. 2000;924:17-25. (Pubitemid 32050177)
6. Zhu D, Shi J, Zhang Y, et al. Central angiotensin II stimulation promotes β amyloid production in Sprague Dawley rats. PLoS One. 2011;6(1):e16037.
7. Wang J, Ho L, Chen L, et al. Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest. 2007;117(11):3393-3402. (Pubitemid 350096995)
8. Danielyan L, Klein R, Hanson LR, et al. Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease. Rejuvenation Res. 2010;13(2-3):195-201.
9. Paglieri C, Bisbocci D, Di Tullio MA, Tomassoni D, Amenta F, Veglio F. Arterial hypertension: a cause of cognitive impairment and of vascular dementia. Clin Exp Hypertens. 2004;26(4):277-285. (Pubitemid 38685920)
10. Sharp SI, Aarsland D, Day S, Sønnesyn H, Ballard C; Alzheimer's Society Vascular Dementia Systematic Review Group. Hypertension is a potential risk factor for vascular dementia: systematic review. Int J Geriatr Psychiatry. 2011;26(7):661-669.
11. Beekly DL, Ramos EM, van Belle G, et al; NIA-Alzheimer's Disease Centers. The National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database. Alzheimer Dis Assoc Disord. 2004;18(4):270-277. (Pubitemid 40076162)
12. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease: a primer for practicing pathologists. Arch Pathol Lab Med. 1993;117(2):132-144. (Pubitemid 23057613)
13. Khachaturian ZS. Revised criteria for diagnosis of Alzheimer's disease: National Institute on Aging-Alzheimer's Association diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):253-256.
14. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239-259.
15. Nagy Z, Yilmazer-Hanke DM, Braak H, Braak E, Schultz C, Hanke J. Assessment of the pathological stages of Alzheimer's disease in thin paraffin sections: a comparative study. Dement Geriatr Cogn Disord. 1998;9(3):140-144. (Pubitemid 28171885)
16. Roman GC. Senile dementia of the Binswanger type: a vascular form of dementia in the elderly. JAMA. 1987;258(13):1782-1788. (Pubitemid 18092206)
17. Hoffman LB, Schmeidler J, Lesser GT, et al. Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons. Neurology. 2009;72(20):1720-1726.
18. Hu J, Igarashi A, Kamata M, Nakagawa H. Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J Biol Chem. 2001;276(51):47863-47868.
19. Langbaum JB, Chen K, Launer LJ, et al. Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons. Neurobiol Aging. 2011;33(4):827-, e11-e19.